Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02180321Completed
Randomised trial of tranexamic acid in Craniosynostosis (2 arms), sponsored by Yonsei University. Primary endpoint: Bleeding loss at 48 hours. Started Jun 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02180321.